May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Clinical Characterization of RP11 in Five Families With Identified PRPF31 Mutations
Author Affiliations & Notes
  • D.G. Birch
    Retina Foundation of the Southwest, Dallas, TX
    Rose–Silverthorne Laboratory, Human Genetics Laboratory,
  • D.H. Wheaton
    Retina Foundation of the Southwest, Dallas, TX
    Southwest Eye Registry, Human Genetics Center,
  • K.G. Locke
    Retina Foundation of the Southwest, Dallas, TX
    Rose–Silverthorne Laboratory, Human Genetics Laboratory,
  • S.J. Bowne
    Rose–Silverthorne Laboratory, Human Genetics Laboratory,
    UT–Houston, Houston, TX
  • L.S. Sullivan
    Rose–Silverthorne Laboratory, Human Genetics Laboratory,
    UT–Houston, Houston, TX
  • S.P. Daiger
    Southwest Eye Registry, Human Genetics Center,
    UT–Houston, Houston, TX
  • Footnotes
    Commercial Relationships  D.G. Birch, None; D.H. Wheaton, None; K.G. Locke, None; S.J. Bowne, None; L.S. Sullivan, None; S.P. Daiger, None.
  • Footnotes
    Support  NIH Grant EY05235, NIH Grant EY07142, and FFB
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1037. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D.G. Birch, D.H. Wheaton, K.G. Locke, S.J. Bowne, L.S. Sullivan, S.P. Daiger; Clinical Characterization of RP11 in Five Families With Identified PRPF31 Mutations . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1037.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Mutations in the pre–mRNA splicing gene PRPF31 cause RP11, a form of autosomal dominant RP characterized by non–penetrance in some obligate carriers. The variations in expression of wild type PRPF31 which are suspected of causing non–penetrance might also be expected to produce large variations in disease severity among affected individuals. We therefore characterized visual function in members from five affected pedigrees.

Methods: : Affected (n=14; 9–65 yrs) and unaffected individuals (n=6; 5–62 yrs) from five families volunteered for the study. In addition to a routine ophthalmologic examination, visual function assessment included visual acuity, static perimetric thresholds, rod absolute thresholds, full–field electroretinography, and fundus photography.

Results: : Four families had termination or missense mutations in PRPF31. Patients in these families were diagnosed at an early age and experienced early peripheral field loss. Rod ERG responses were non–detectable in all (n=12) including children as young as age 9 yrs. Cone responses were typically in the sub–microvolt range with delayed implicit time. Nevertheless, macula function (visual acuity, cone perimetric thresholds and rod absolute thresholds) was relatively well preserved. Even in families with reduced penetrance (i.e., completely normal results on all tests in an unaffected 62–year–old obligate carrier), there was little variability in phenotype among the affected family members. In a fifth family with a splice–site mutation, there was greater variability with one individual retaining a 33 µV cone ERG and measurable rod ERG function into adulthood.

Conclusions: : Despite variations in age and mutation among these patients, a fairly consistent phenotype emerged. Most patients showed early field and ERG loss with relative preservation of central retinal function. This uniformity of phenotype is not consistent with the range of severity expected due to continuous variation in expression of the wild–type allele, but is consistent with a dichotomous trait or a threshold model.

Keywords: retinal degenerations: hereditary • electroretinography: clinical • photoreceptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×